Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has c... Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. 더 보기
SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...
SAN FRANCISCO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.64 | 10.9777015437 | 5.83 | 6.61 | 5.72 | 1623513 | 6.15449724 | CS |
4 | 0.875 | 15.6389633601 | 5.595 | 6.61 | 4.6 | 1435212 | 5.67005562 | CS |
12 | -5.85 | -47.4837662338 | 12.32 | 13.06 | 4.6 | 1126487 | 6.9126994 | CS |
26 | -9.15 | -58.5787451985 | 15.62 | 16.62 | 4.6 | 775070 | 9.00519724 | CS |
52 | -5.74 | -47.0106470106 | 12.21 | 16.775 | 4.6 | 829964 | 10.67271241 | CS |
156 | 0.52 | 8.73949579832 | 5.95 | 17.7911 | 2 | 528522 | 9.36927657 | CS |
260 | -40.53 | -86.2340425532 | 47 | 60.27 | 2 | 477714 | 12.10966669 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관